Robert Shahverdyan, MD is an internationally acclaimed Vascular Access surgeon. He is board certified vascular and endovascular surgeon based in Hamburg, Germany with special interest and >15 years extensive experience in the field of dialysis access (specifically arteriovenous shunt), including being Head of Vascular Access Center for >7 years. He is renowned for developing innovative approaches to vascular access surgery, advancing patient outcomes, and contributing to cutting-edge research in the field. A prolific author and educator, with numerous publications in prestigious journals and active roles in international committees, including the recent European Society of Vascular Surgery's Vascular Access Guidelines. Skilled in mentoring and lecturing, with a passion for sharing expertise through medical schools and professional masterclasses, Dr. Shahverdyan is fluent in German, English, Armenian and Russian, with a proven ability to collaborate across cultures and disciplines. Committed to excellence in surgical care, advancing medical innovation, and fostering a culture of continuous learning in the global medical community, Dr. Shahverdyan was the first surgeon worldwide to perform endovascular arteriovenous fistula creation with both approved devices (WavelinQ and Ellipsys) and was part of the first in human (FIH) trial of the next generation endovascular arteriovenous fistula Velocity device, where he also serves as an advisory board member. He was one of the first adopters of endovascular AVF creation and is considered as one of the most experienced in the world. As an internationally recognized expert in the field, he provides you with best possible and tailored care, starting with preoperative planing, vascular access creation and postoperative care. Additionally, on his website he shares additional information, recorded lectures, publications, case presentations, and consultations for patients with chronic or end-stage kidney disease.